CAR-T Cell Therapies Entering the Mainstream of Cancer Clinical Trials & Treatment

KEY LEARNING OBJECTIVES

• Audience will have an understanding how Medidata can have an impact with Clinical Trial pharma and bio tech firms that are working in this therapeutic area
• What are the challenges that CAR-T developers face and how can data help address those challenges
• How is Medidata AI “data” different from other data providers